Japan's health ministry looks set to let registered drug sellers dispense oral loxoprofen, taking Daiichi Sankyo Healthcare's ...
A survey of 194 life sciences and medtech professionals showed that 63% expect AI investments to rise in 2027 with the ...
Japan's latest batch of approval recommendations include global-first nods for anselamimab for kappa light chain amyloidosis ...
A Pew survey of 3,488 US adults finds 72% want to be told if AI is used in their care and 46% do not know if it has already ...
The FDA has selected Epitel's wearable EEG system and Prapela's infant cardiac device as the first participants in its ...
The FDA approval of Gilead’s once-daily combination of bictegravir and lenacapavir opens a new option for the minority of ...
The FDA approved the oral suspension tablet formulation of Tivicay for children from 4 weeks of age to under 6 years, a ...
The FDA has issued another early alert involving Abiomed’s Automated Impella Controllers, citing a purge cassette recognition ...
The Swiss biotech still has big pharma partnerships in Alzheimer's disease but is putting more focus on developing its ...
Several organizations argue that the US Trade Representative should drop its investigation into German drug pricing policies.
The FDA seeks ideas for incentives to sustain stakeholder investment in the new Quantitative Medicine Innovation Network, ...
AstraZeneca and Amgen’s thymic stromal lymphopoietin inhibitor, which is already approved for severe asthma and chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results